{"id":"gsk208141-vaccine","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a therapeutic cancer vaccine, GSK208141 works by priming T cells and other immune effectors to target malignant cells. The vaccine formulation likely contains tumor-associated peptide antigens combined with an immunological adjuvant to enhance immune activation and durability of the anti-tumor response.","oneSentence":"GSK208141 is a therapeutic vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:14:39.215Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer immunotherapy (specific indication under investigation in phase 3)"}]},"trialDetails":[{"nctId":"NCT00224484","phase":"PHASE3","title":"Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-04-07","conditions":"Herpes Simplex","enrollment":5960},{"nctId":"NCT00698893","phase":"PHASE1","title":"Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"1992-05-01","conditions":"Herpes Simplex","enrollment":16},{"nctId":"NCT00224471","phase":"PHASE3","title":"Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-12","conditions":"Herpes Simplex","enrollment":671},{"nctId":"NCT00699764","phase":"PHASE3","title":"Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"1996-03","conditions":"Herpes Simplex","enrollment":2491},{"nctId":"NCT00698568","phase":"PHASE3","title":"Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"1996-10","conditions":"Prophylaxis for Herpes Simplex","enrollment":7460},{"nctId":"NCT00698490","phase":"PHASE1, PHASE2","title":"Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"1995-08","conditions":"Prophylaxis Herpes Simplex","enrollment":130},{"nctId":"NCT00697567","phase":"PHASE2","title":"Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"1992-09","conditions":"Prophylaxis Herpes Simplex","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":306030,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Herpes simplex vaccine"],"phase":"phase_3","status":"active","brandName":"GSK208141 vaccine","genericName":"GSK208141 vaccine","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"GSK208141 is a therapeutic vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens. Used for Cancer immunotherapy (specific indication under investigation in phase 3).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}